Open Label, Multicenter Study to Evaluate Safety, Local Tolerability, Convenience, and Efficacy of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006842/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This study is being conducted to explore the clinical safety, local tolerability, convenience
and effectiveness of self-treatment of hereditary angioedema (HAE) attacks with subcutaneous
injections of icatibant.
提供机构：
Vivli
创建时间：
2021-04-07
